Motor Intervention Whit the Intorus Tool on Children With Down Syndrome
Primary Purpose
Down Syndrome
Status
Active
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
INTORUS
Sponsored by
About this trial
This is an interventional treatment trial for Down Syndrome focused on measuring Down syndrome, psychomotoricity
Eligibility Criteria
Inclusion Criteria: Users with Down Syndrome Ages between 4 and 18 years. Informed consent signed by parents/guardians. Exclusion Criteria: Users without Down Syndrome. Under 4 years and over 18 years
Sites / Locations
- Blanca Gonzalez Sanchez
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
experimental group
control group
Arm Description
Group that will receive the intervention sessions using the Intorus tool
Group that will receive the intervention sessions without using the Intorus tool
Outcomes
Primary Outcome Measures
Change in Pediatric Balanced Scale
The Pediatric Balance Scale is a modified version of the Berg Balance Scale that is used to assess functional balance skills in school-aged children. The scale consists of 14 items that are scored from 0 points (lowest function) to 4 points (highest function) with a maximum score of 56 points
Change in Berg Equilibrium Scale
Scale for measuring balance in people over 15 years of age. The Berg Balance Scale (BBS) is used to objectively determine a patient's ability (or inability) to safely balance during a series of predetermined tasks. It is a 14 item list with each item consisting of a five-point ordinal scale ranging from 0 to 4, with 0 indicating the lowest level of function and 4 the highest level of function and takes approximately 20 minutes to complete. It does not include the assessment of gait.
Secondary Outcome Measures
Change in Harris test
Scale for assessing lateralisation. In this way, it is possible to find out whether the child has a rightward, leftward, ambidextrous, incomplete, crossed or opposite laterality dominance.
Full Information
NCT ID
NCT05740046
First Posted
January 30, 2023
Last Updated
February 21, 2023
Sponsor
University of Extremadura
1. Study Identification
Unique Protocol Identification Number
NCT05740046
Brief Title
Motor Intervention Whit the Intorus Tool on Children With Down Syndrome
Official Title
Influence of Motor Intervention With the Intorus Tool on the Psychomotor Development of Children With Down Syndrome
Study Type
Interventional
2. Study Status
Record Verification Date
February 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
February 1, 2023 (Actual)
Primary Completion Date
June 30, 2023 (Anticipated)
Study Completion Date
July 31, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Extremadura
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The goal of this clinical trial is to test in people with down syndrome how does the INTORUS tool influence their psychomotor development. The main question it aims to answer is:
- Does the INTORUS tool improve psychomotor development in people with Down Syndrome? The intervention program will be carried out during the Functional Habilitation sessions and will be carried out by the center's professionals. These sessions must be carried out in a quiet environment, without distractions so that the user can concentrate on carrying out the activities. It is important that the user attends the sessions in comfortable, sleeveless clothing, to allow the tool to slide smoothly through their upper limbs.
Each session will consist of several exercises with their corresponding rest breaks described in the Intervention Protocol. Each session attendance will be recorded following an attendance record model created for the occasion.
Participants will be divided into two groups randomly. The control group will receive an intervention treatment at the psychomotor level in the traditional way, following the protocols established in the center, and the intervention group will receive an intervention treatment at the psychomotor level with the INTORUS device.
Randomization will be carried out using the Oxford Minimization and Randomization software.
Detailed Description
POPULATION The population of interest are users of the Functional Habilitation Service of the Centers of the Down Syndrome Association of Cáceres and Plasencia
INCLUSION CRITERIA
Users with Down Syndrome
Ages between 4 and 18 years.
Informed consent signed by parents/guardians.
EXCLUSION CRITERIA
Users without Down Syndrome.
Under 4 years and over 18 years.
A total of approximately 100 users will participate in the study. Participants will be divided into two groups randomly. The control group will receive an intervention treatment at the psychomotor level in the traditional way, following the protocols established in the center, and the intervention group will receive an intervention treatment at the psychomotor level with the INTORUS device.
Randomization will be carried out using the OxMaR (Oxford Minimization and Randomization) software.
PROJECT REGISTRATION The project has been approved by the Bioethics and Biosafety Commission of the University of Extremadura as of 12/19/2022.
INTERVENTION PROGRAM
The intervention program will be carried out during the Functional Habilitation sessions and will be carried out by the center's professionals. These sessions must be carried out in a quiet environment, without distractions so that the user can concentrate on carrying out the activities. It is important that the user attends the sessions in comfortable, sleeveless clothing, to allow the tool to slide smoothly through their upper limbs.
Each session will consist of several exercises with their corresponding rest breaks described in the Intervention Protocol. Each session attendance will be recorded following an attendance record model created for the occasion.
INTERVENTION PROTOCOL
To carry out the intervention sessions, all participants will follow the same protocol for the use of INTORUS. It is a protocol created for the study of increasing difficulty in which the participants advance to a higher level once they have passed the lower level.
EVALUATION
The evaluations will be carried out prior to the start of treatment, at 20 weeks of treatment and at 40 weeks of treatment once the intervention program has concluded.
The tools used to carry out the evaluation will be:
Questionnaire of participating sociodemographic variables
Pediatric Balanced Scale (PBS)
Berg Balance Scale
Harris test. Adaptation of the Harris Test of Lateral Dominance
Single leg support time on a stable surface
Satisfaction questionnaire for professionals
Participant satisfaction questionnaire adapted to easy reading. The evaluations will be carried out by a professional external to the treatment to avoid bias.
Once the intervention period is over, a questionnaire will be passed to the professionals participating in the study to assess the usefulness of the device, the degree of satisfaction with it and the usefulness of the therapies applied, and a satisfaction questionnaire for participants adapted for easy reading. to know the degree of satisfaction and usefulness of the tool on the part of the participants.
TIMELINE
The intervention consists of 40 treatment sessions lasting 45 minutes each with a frequency of 2 days a week in which the intervention protocol described in Annex 7 described above will be developed. (15 min from Intorus) Previously, the participants will receive a "session 0" in which they will carry out a first contact with the device.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Down Syndrome
Keywords
Down syndrome, psychomotoricity
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
30 (Actual)
8. Arms, Groups, and Interventions
Arm Title
experimental group
Arm Type
Experimental
Arm Description
Group that will receive the intervention sessions using the Intorus tool
Arm Title
control group
Arm Type
No Intervention
Arm Description
Group that will receive the intervention sessions without using the Intorus tool
Intervention Type
Device
Intervention Name(s)
INTORUS
Intervention Description
INTERVENTION PROTOCOL WITH INTORUS
Primary Outcome Measure Information:
Title
Change in Pediatric Balanced Scale
Description
The Pediatric Balance Scale is a modified version of the Berg Balance Scale that is used to assess functional balance skills in school-aged children. The scale consists of 14 items that are scored from 0 points (lowest function) to 4 points (highest function) with a maximum score of 56 points
Time Frame
Before starting the interventions, at 3 months and at 6 months at the end of the study.
Title
Change in Berg Equilibrium Scale
Description
Scale for measuring balance in people over 15 years of age. The Berg Balance Scale (BBS) is used to objectively determine a patient's ability (or inability) to safely balance during a series of predetermined tasks. It is a 14 item list with each item consisting of a five-point ordinal scale ranging from 0 to 4, with 0 indicating the lowest level of function and 4 the highest level of function and takes approximately 20 minutes to complete. It does not include the assessment of gait.
Time Frame
Before starting the interventions, at 3 months and at 6 months at the end of the study.
Secondary Outcome Measure Information:
Title
Change in Harris test
Description
Scale for assessing lateralisation. In this way, it is possible to find out whether the child has a rightward, leftward, ambidextrous, incomplete, crossed or opposite laterality dominance.
Time Frame
Before starting the interventions, at 3 months and at 6 months at the end of the study.
Other Pre-specified Outcome Measures:
Title
PROFESSIONAL SATISFACTION
Description
Questionnaire to measure the degree of satisfaction of the professionals participating in the study with the use of the tool.
Time Frame
through study completion, an average of 5 months
Title
PARTICIPANTS SATISFACTION
Description
Questionnaire to measure the degree of satisfaction of the participants in the study with the use of the tool.
Time Frame
through study completion, an average of 5 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
4 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Users with Down Syndrome
Ages between 4 and 18 years.
Informed consent signed by parents/guardians.
Exclusion Criteria:
Users without Down Syndrome.
Under 4 years and over 18 years
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
BLANCA GONZÁLEZ SÁNCHEZ, DOCTOR
Organizational Affiliation
UNIERSIDAD DE EXTREMADURA
Official's Role
Principal Investigator
Facility Information:
Facility Name
Blanca Gonzalez Sanchez
City
Caceres
ZIP/Postal Code
10001
Country
Spain
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Motor Intervention Whit the Intorus Tool on Children With Down Syndrome
We'll reach out to this number within 24 hrs